ASP-2957

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameASP-2957
Drug Alias NameMyoAAV3.8 engineered capsid-myosin heavy chain kinase 7-human myotubularinASP2957ASP-2957MyoAAV3.8-MHCK7-hMTM1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > MyoAAV vector
Mechanisms of ActionMyotubularin expression stimulantsGene transference
TargetsMyotubularin
Therapy Area/IndicationsMyopathies, Structural, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Gene Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Gene Therapies Inc
Inactive CompaniesN/A
Active IndicationsMyopathies, Structural, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A